Merck KGaA's generics business
GPTKB entity
Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
business
|
| gptkbp:collaboratesWith |
healthcare_organizations
|
| gptkbp:competesWith |
other generic drug manufacturers
|
| gptkbp:develops |
generic formulations
|
| gptkbp:employs |
pharmacists
|
| gptkbp:focusesOn |
generic pharmaceuticals
|
| gptkbp:hasHistoricalSignificance |
gptkb:Darmstadt
|
| gptkbp:hasPart |
sales department
R&D department marketing team regulatory affairs team |
| gptkbp:hasResidence |
€1 billion
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merck KGaA's generics business
|
| gptkbp:isActiveIn |
global markets
|
| gptkbp:isEngagedIn |
advocacy efforts
community outreach customer service market research networking events regulatory affairs |
| gptkbp:isFocusedOn |
innovation
patient safety market access patient access |
| gptkbp:isIncorporatedIn |
Merck KGaA
|
| gptkbp:isInvolvedIn |
educational programs
patient education regulatory compliance partnerships product development supply chain management supply chain optimization clinical research |
| gptkbp:isKnownFor |
affordable medications
cost-effective solutions therapeutic areas therapeutic innovation |
| gptkbp:isLinkedTo |
sustainability initiatives
|
| gptkbp:isLocatedIn |
gptkb:Germany
|
| gptkbp:isPartOf |
gptkb:Merck_Group
corporate strategy global health initiatives business development. global strategy pharmaceutical division healthcare_ecosystem |
| gptkbp:isRecognizedFor |
quality standards
|
| gptkbp:isRegulatedBy |
gptkb:FDA
|
| gptkbp:isSupportedBy |
clinical trials
data analytics research funding logistics services financial resources scientific expertise IT systems |
| gptkbp:offers |
generic drugs
|
| gptkbp:operatesIn |
pharmaceutical industry
|
| gptkbp:partOf |
Merck KGaA
|
| gptkbp:provides |
medicinal products
|
| gptkbp:targets |
healthcare_providers
|
| gptkbp:wasFoundedIn |
1995
|